Candriam S.C.A. reduced its holdings in shares of The Allstate Corporation (NYSE:ALL – Free Report) by 21.2% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 164,313 shares of the insurance provider’s stock after selling 44,196 shares during the period. Candriam S.C.A. owned about 0.06% of Allstate worth $33,079,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also modified their holdings of the business. Arlington Trust Co LLC raised its holdings in Allstate by 261.8% in the 2nd quarter. Arlington Trust Co LLC now owns 123 shares of the insurance provider’s stock worth $25,000 after purchasing an additional 89 shares during the period. Caitong International Asset Management Co. Ltd increased its position in Allstate by 315.0% in the second quarter. Caitong International Asset Management Co. Ltd now owns 166 shares of the insurance provider’s stock worth $33,000 after buying an additional 126 shares in the last quarter. Hilltop National Bank bought a new position in shares of Allstate in the second quarter worth about $34,000. Meeder Asset Management Inc. lifted its position in shares of Allstate by 113.8% during the 1st quarter. Meeder Asset Management Inc. now owns 186 shares of the insurance provider’s stock valued at $39,000 after buying an additional 99 shares in the last quarter. Finally, Chilton Capital Management LLC bought a new position in shares of Allstate during the 2nd quarter valued at approximately $38,000. Hedge funds and other institutional investors own 76.47% of the company’s stock.
Allstate Stock Performance
Shares of NYSE ALL opened at $209.16 on Thursday. The company has a market cap of $54.73 billion, a P/E ratio of 9.83, a P/E/G ratio of 0.69 and a beta of 0.35. The Allstate Corporation has a 52-week low of $176.00 and a 52-week high of $215.70. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.43 and a current ratio of 0.43. The firm’s fifty day moving average is $202.04 and its two-hundred day moving average is $201.45.
Wall Street Analyst Weigh In
Several equities analysts have weighed in on ALL shares. Cantor Fitzgerald raised shares of Allstate to a “hold” rating in a report on Wednesday, August 13th. Citigroup upgraded shares of Allstate to a “hold” rating in a research report on Wednesday, August 13th. Jefferies Financial Group lifted their target price on shares of Allstate from $254.00 to $255.00 and gave the company a “buy” rating in a research note on Monday, August 11th. Morgan Stanley increased their price target on Allstate from $235.00 to $245.00 and gave the stock an “overweight” rating in a research note on Friday, August 1st. Finally, Wall Street Zen downgraded Allstate from a “strong-buy” rating to a “buy” rating in a research report on Saturday, November 8th. Two investment analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $237.13.
Read Our Latest Report on Allstate
Allstate Company Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Stories
- Five stocks we like better than Allstate
- Stock Market Upgrades: What Are They?
- Rare Earth Stocks: The Truce That Isn’t a Truce
- The Risks of Owning Bonds
- Carving Up Profits: 3 Food Stocks on the Thanksgiving Table
- High Flyers: 3 Natural Gas Stocks for March 2022
- C3.ai’s Reset: Why New Leadership Could Spark a Turnaround
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
